Sandy Hook is getting a bar and restaurant

The National Park Service has announced that one of the historic buildings at Fort Hancock in Sandy Hook will be converted to a bar and restaurant, probably this summer.

A 6,000-square-foot mule barn will be converted into a dining and drinking establishment with outdoor seating and year-round service, according to Asbury Park Press.

According to APP.com, a shuttle service is being planned for the brewery that will bring visitors from other parts of the park to the business.

The development is part of the park service’s attempt to lease some of the closed (and in some cases, dilapidated) historic buildings at Fort Hancock. They have received a proposal to convert 21 of the buildings into 93 apartments while maintaining the buildings’ historic facades. They are also accepting proposals to renovate other buildings at Fort Hancock and Sandy Hook.

The apartment proposal is not without controversy. There are environmental concerns, including the feasibility of testing parking for 93 units on what is basically a narrow strip of land. It also considers what the increase in human population will do to the park’s ecosystem.

The views expressed in the above post are solely those of New Jersey 101.5 talk show host Bill Doyle.

Now you can listen to Deminski & Doyle – On demand! Listen to New Jersey’s favorite evening radio show any day of the week. Download the Deminski & Doyle show wherever you get podcasts, in our free app or listen right now:

LOOK: History of food from the year you were born

From product innovations to major recalls, Stacker investigated what happened in food history every year since 1921, according to government news and sources.

Take a look at the most expensive home for sale in Somerset County

Omicron’s Impact on New Jersey COVID Cases

As the COVID-19 pandemic approaches its third calendar year in New Jersey, some things have remained true (hand washing, tips for vaccinating), while others have evolved alongside the latest variant (fewer treatments with monoclonal antibodies, new anti-viral pills).

.